Worldwide, an estimated 2,964,197 new female breast cancer cases are projected to occur in 2040, a 31% increase from the corresponding 2,260,127 cases in 2020. Conclusions: There is significant variation in female breast cancer incidence and mortality rates worldwide. Breast cancer incidence ...
Xu, Y., Gong, M., Wang, Y.et al.Global trends and forecasts of breast cancer incidence and deaths.Sci Data10, 334 (2023). https://doi.org/10.1038/s41597-023-02253-5 Download citation Received02 March 2023 Accepted18 May 2023
In 2024, the global breast cancer therapeutics market continues to grow rapidly, building on its valuation of $34 billion in 2023 and projected to reach $66 billion by 2032, with a steady CAGR of 6.8%. This growth is fueled by an increasing global incidence of breast cancer, coupled with ...
February 20th 2023 Incidence of regional tumor recurrence in patients with HR–positive breast cancer did not significantly differ between patients who received post operational radiotherapy. Read More Novel Therapies Show Promise in HER2-Low Metastatic Breast Cancer ...
Prognostic impact of extracranial disease control in HER2+ breast cancer-related brain metastases Article Open access 30 January 2023 Survival and disease characteristics of de novo versus recurrent metastatic breast cancer in a cohort of young patients Article Open access 31 March 2020 Back...
Background and aim Breast cancer (BC) is one of the leading causes of cancer deaths in females in South America. This study aims to examine the BC burden i... S Rajesh - 《Breast Cancer Research & Treatment》 被引量: 0发表: 2023年 Global patterns of breast cancer incidence and mortalit...
Based on the findings, we further outlined different suggestions for future breast cancer interventions for diverse population. 2. Methods Data source. In this study, data of ASR (world) of breast cancer incidence and mortality rate per 100,000 population for both sexes by age groups, continents...
2. Chen Z, et al. Is HER2 ultra‑low breast cancer different from HER2 null or HER2 low breast cancer? A study of 1363 patients. Breast Cancer Res Treat. 2023 Nov;202(2):313-323. 3. Manohar P, et al. Updates in endocrine therapy for metastatic breast cancer. Cancer Biol Med. 20...
Article Open access 27 July 2023 Introduction Triple-negative breast cancer ranks among the most aggressive types of breast cancer, and its name is attributed to the lack of three major receptors conventionally targeted for breast cancer treatment. These include receptors for HER2 (epidermal growth fa...
We describe temporal trends in breast cancer incidence by molecular subtypes in Scotland because public health prevention programmes, diagnostic and therapeutic services are shaped by differences in tumour biology. Population-based cancer registry data o